Amgen Revenue decreased by 12.6% to $8.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $8.15B to $8.62B. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.53B | $6.71B | $6.85B | $6.24B | $6.59B | $6.65B | $6.84B | $6.11B | $6.99B | $6.90B | $8.20B | $7.45B | $8.39B | $8.50B | $9.09B | $8.15B | $9.18B | $9.56B | $9.87B | $8.62B |
| QoQ Change | — | +2.8% | +2.1% | -8.9% | +5.7% | +0.9% | +2.8% | -10.7% | +14.4% | -1.2% | +18.7% | -9.1% | +12.6% | +1.4% | +6.9% | -10.3% | +12.6% | +4.1% | +3.2% | -12.6% |
| YoY Change | — | — | — | — | +1.0% | -0.8% | -0.1% | -2.1% | +5.9% | +3.8% | +19.8% | +22.0% | +20.1% | +23.2% | +10.9% | +9.4% | +9.4% | +12.4% | +8.6% | +5.8% |